This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Syneos Health (SYNH) For Now
by Zacks Equity Research
Investors are optimistic about Syneos Health (SYNH), given the strength in its Clinical Solutions business and notable partnership deals.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
by Zacks Equity Research
Solid shareholder-friendly measures and strong healthcare-specific global IT infrastructure boost IQVIA Holdings (IQV) shares.
IQVIA Holdings' (IQV) Stock Up 44% Year to Date: Here's Why
by Zacks Equity Research
Encouraging yearly guidance and consecutive better-than-expected top- and bottom-line performances have been aiding IQVIA Holdings' (IQV) stock.
IQVIA (IQV) Announces Collaboration With NRx Pharmaceuticals
by Zacks Equity Research
IQVIA (IQV) and NRx are set to work closely to support activities essential for emergency use authorization of ZYESAMI.
Veeva Systems (VEEV) Q2 Earnings Beat Estimates, '22 View Up
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q2 results reflect impressive performances by both its segments.
Why Is IQVIA (IQV) Up 5.4% Since Last Earnings Report?
by Zacks Equity Research
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IQVIA (IQV) Banking on Global IT Infrastructure, Debt Woe Stays
by Zacks Equity Research
IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.
Visa (V) Q3 Earnings Beat Estimates, Revenues Improve Y/Y
by Zacks Equity Research
Visa's (V) fiscal third-quarter results highlight improved payments volume, processed transactions and cross-border volume, partly offset by high operating costs.
IQVIA (IQV) Beats on Q2 Earnings & Revenues, Raises 2021 View
by Zacks Equity Research
IQVIA's (IQV) second-quarter 2021 earnings and revenues increase year over year.
IQVIA Holdings (IQV) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 2.90% and 5.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for IQVIA Holdings (IQV) in Q2 Earnings?
by Zacks Equity Research
IQVIA's (IQV) second-quarter 2021 earnings and revenues are expected to have improved year over year.
Equifax (EFX) Beats on Q2 Earnings & Revenues, Ups '21 View
by Zacks Equity Research
Equifax's (EFX) second-quarter 2021 earnings and revenues increase year over year.
Zacks Industry Outlook Highlights: IQVIA Holdings, Seagate Technology and Blucora
by Zacks Equity Research
Zacks Industry Outlook Highlights: IQVIA Holdings, Seagate Technology and Blucora
3 Technology Services Stocks to Watch Out For Despite Industry Woes
by Sanjana Goswami
The coronavirus-driven dependency on technology, increased digitization and growing adoption of the multi-cloud model should help the Zacks Technology Services industry thrive. IQV, STX and BCOR are well positioned to witness demand surge.
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ManpowerGroup (MAN) Q2 Earnings & Revenues Beat, Up Y/Y
by Zacks Equity Research
ManpowerGroup's (MAN) second-quarter 2021 earnings and revenues improve year over year.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
by Zacks Equity Research
IQVIA's (IQV) unique ability to standardize, organize and integrate information through applying sophisticated analytics and global technology infrastructure helps it build a strong client base.
IQVIA Holdings (IQV) Stock Up 74.6% Over a Year: Here's Why
by Zacks Equity Research
Encouraging yearly guidance and consecutive better-than-expected top- and bottom-line performances has been aiding IQVIA Holdings (IQV) stock.
IQVIA (IQV) Announces Launch of Clinical Data Analytics Suite
by Zacks Equity Research
IQVIA's (IQV) new platform brings benefits such as real-time data management, reduced data-harmonization efforts, reduced time of KPI deployment and improved decision making.
IQVIA Holdings (IQV) Stock Up 55.4% Over a Year: Here's Why
by Zacks Equity Research
IQVIA Holdings (IQV) stock is riding on consecutive better-than-expected top- and bottom-line performances, and an encouraging yearly guidance.
DocuSign (DOCU) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DocuSign's (DOCU) first-quarter fiscal 2022 earnings are expected to have benefited from improvement in operational efficiency.
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Consecutive better-than-expected top- and bottom-line performances, along with an encouraging yearly guidance, have been aiding IQVIA Holdings (IQV) stock.
Here is Why Growth Investors Should Buy IQVIA (IQV) Now
by Zacks Equity Research
IQVIA (IQV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ExlService Holdings (EXLS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
ExlService Holdings (EXLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.